What research findings exist for MK677 regarding GH secretion, lean body mass, and body composition?
GH, IGF-I, and lean body mass increase. Other studies report: MK-677 improves negative nitrogen balance, supporting anti-catabolic research.[1] ↗ [2] ↗
Currently, 3 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.
Comparison of study design and results
Results from different populations, species, materials, or follow-up times cannot be directly combined. The table below is a comparative summary of published data, not new experimental data.
| Literature | Study subjects and design | Observation and discovery | Scope of Explanation |
|---|---|---|---|
| 1998 · PMID 9467542 | 24 obese men; 8-week oral MK-677 randomized double-blind trial | GH, IGF-I, and lean body mass increase. | Total and visceral fat did not significantly decrease, glucose tolerance is affected; this is not equivalent to muscle strength, fat loss, or bottled usage. |
| 1998 · PMID 9467534 | Random double-blind human condition; Dietary restriction condition | MK-677 improves negative nitrogen balance, supporting anti-catabolic research. | 1998 Short-term physiological study, cannot be turned into long-term muscle gain claims. |
| 1996 · PMID 8954023 | Healthy elderly adults; 4-week oral study | GH pulses and IGF-I increase, offering endocrinology development significance. | 1996; accompanied by increased fasting blood glucose, cannot be described as safe anti-aging or guaranteed health benefits. |
References
With lean body weight gain, does fat reduction also occur?
GH, IGF-I, and lean body mass increase.[1] ↗
24 obese men; 8-week oral MK-677 randomized double-blind trial
Total and visceral fat did not significantly decrease, glucose tolerance is affected; this is not equivalent to muscle strength, fat loss, or bottled usage.
View the Article Title and Full Citation＋
Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
The Journal of Clinical Endocrinology and Metabolism · Volume, Issue, Year 1998
First published 1998-02-01 · PMID 9467542
DOI 10.1210/jcem.83.2.4539
How does nitrogen balance change under dietary restriction conditions?
MK-677 improves negative nitrogen balance, supporting anti-catabolic research.[2] ↗
Random double-blind human condition; Dietary restriction condition
1998 Short-term physiological study, cannot be turned into long-term muscle gain claims.
View the Article Title and Full Citation＋
MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
The Journal of Clinical Endocrinology and Metabolism · Volume, Issue, Year 1998
First published 1998-02-01 · PMID 9467534
DOI 10.1210/jcem.83.2.4551
What does the GH and IGF-I physiology study in healthy elderly reveal?
GH pulses and IGF-I increase, offering endocrinology development significance.[3] ↗
Healthy elderly adults; 4-week oral study
1996; accompanied by increased fasting blood glucose, cannot be described as safe anti-aging or guaranteed health benefits.
View the Article Title and Full Citation＋
Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects.
The Journal of Clinical Endocrinology and Metabolism · Volume, Issue, Year 1996
First published 1996-12-01 · PMID 8954023.
DOI 10.1210/jcem.81.12.8954023
Common issues and corresponding evidence
What research findings exist for MK677 regarding GH secretion, lean body mass, and body composition?＋
GH, IGF-I, and lean body mass increase. Other studies report: MK-677 improves negative nitrogen balance, supporting anti-catabolic research.[1] ↗ [2] ↗
Does MK-677 increasing lean body mass indicate fat loss or increased muscle strength?＋
Does not represent. In an 8-week human trial, lean body mass increased, but total fat and visceral fat did not decrease significantly, and there were changes in glucose tolerance; it cannot be taken as a promise of fat loss or strength increase.[1] ↗
MK677—these conclusions apply to which study populations?＋
24 obese men; 8-week oral MK-677 randomized double-blind trial; human randomized double-blind; dietary restriction conditions; healthy older adults; 4 weeks oral. Total fat and visceral fat did not drop significantly, glucose tolerance affected; not equivalent to muscle strength, fat loss, or bottle usage.[1] ↗ [2] ↗ [3] ↗
MK677
Return to catalog specifications and batch file verification entry.
